Anakinra
1 NDC across 1 manufacturer|0 Generic,1 Brand
Anakinra is used to treat rheumatoid arthritis and cryopyrin-associated periodic syndromes, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $32 million on Anakinra across 5,321 claims for 921 beneficiaries.
Anakinra is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $192.31 to $192.31 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$192.31 – $192.31
per ML
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ANAKINRA
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
KINERET 100 MG/0.67 ML SYRINGE | $192.3106 per ML | — |
Frequently Asked Questions
What is Anakinra used to treat?
Anakinra is used to treat rheumatoid arthritis and cryopyrin-associated periodic syndromes, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Anakinra?
In 2024, Medicare Part D spent $32 million on Anakinra across 5,321 claims for 921 beneficiaries.
How many Anakinra products are on the market?
The Anakinra drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Anakinra?
NADAC reference prices for Anakinra range from $192.3106 to $192.3106 per ML.
Which manufacturers make Anakinra?
1 manufacturer lists Anakinra in NADAC. Ranked by number of NDCs, the largest are Swedish Orphan Biovitrum AB (publ) (1).